Charles Elliott
Family Medicine · Ripley, MSNPI 1063482404
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $787 and has fallen 97.8% since, to $17 in 2025.
Across 170 payments — averaging $13.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$523
- Novo Nordisk$245
- Sanofi-aventis U.S. LLC$155
- Johnson & Johnson$136
- Mylan Specialty L.p.$113
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$93
- plus $988 from 24 others
What the payments were for
- Food & beverage$2,252100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 47 | $523 |
| Novo Nordisk | 25 | $245 |
| Sanofi-aventis U.S. LLC | 11 | $155 |
| Johnson & Johnson | 12 | $136 |
| Mylan Specialty L.p. | 8 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $93 |
| Bayer | 4 | $85 |
| AstraZeneca | 6 | $85 |
| E.r. Squibb & Sons, L.L.C. | 5 | $76 |
| Amarin Pharma, Inc. | 4 | $71 |
| Astellas Pharma US Inc | 4 | $64 |
| AbbVie | 4 | $61 |
| Boehringer Ingelheim | 3 | $55 |
| Amgen | 4 | $53 |
| Lilly USA, LLC | 4 | $52 |
| GSK | 3 | $49 |
| Novartis | 3 | $42 |
| Abbott | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Biogen | 2 | $36 |
| Dexcom, Inc. | 2 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $22 |
| Boston Scientific | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| Exact Sciences | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$2,252 in reported general payments places this provider in the 70th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Ripley
- Russell CarlisleWesson$1.6M
- Keith StokesLexington$654K
- Walter CarnahanSouthaven$146K
- Karen WhitneyWhitfield$117K
- Dava ClevelandJackson$100K
- Andrea PhillipsJackson$96K
- Kristi TrimmRidgeland$34K
- Tana CooperBiloxi$25K
- Delora DenneyPicayune$24K
- Randall HulingOlive Branch$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.